Sort
40,608 grants matching “prostate cancer”
Erythropoietin Blockade for the Treatment of Cancer
$402,553C. Anthony Blau · University Of Washington · R01 · FY2012 · CA
Genetic Susceptibility for Prostate Cancer Progression
$402,553William B Isaacs · Johns Hopkins University · R01 · FY2007 · CA
64-Bit High Performance Computing
$402,523Edward B Suh · Translational Genomics Research Inst · S10 · FY2007 · RR
Sema3C Signaling as an Alternative Activator of Canonical Wnt Signaling in Glioblastoma
$402,500Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Arginyl-tRNA beyond translation: mechanism and regulation of protein arginylation
$402,500Yi Zhang · Case Western Reserve University · R35 · FY2024 · GM
Arginyl-tRNA beyond translation: mechanism and regulation of protein arginylation
$402,500Yi Zhang · Case Western Reserve University · R35 · FY2023 · GM
Sema3C Signaling as an Alternative Activator of Canonical Wnt Signaling in Glioblastoma
$402,500Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS
Arginyl-tRNA beyond translation: mechanism and regulation of protein arginylation
$402,500Yi Zhang · Case Western Reserve University · R35 · FY2025 · GM
GENETIC ASSOCIATION STUDY OF ANCESTRY-MATCHED AFRICAN AMERICAN PROSTATE CANCER CASES AND CONTROLS
$402,478The Johns Hopkins University · · FY2008 · Department of Defense
CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer
$402,456Scott D Cramer · University Of Colorado Denver · R01 · FY2015 · CA
STAT Activation: Inactivation Cycle and Activated STAT3 in Cancer Cells
$402,453James E Darnell · Rockefeller University · R01 · FY2008 · AI
STAT Activation: Inactivation Cycle and Activated STAT3 in Cancer Cells
$402,453James E Darnell · Rockefeller University · R01 · FY2009 · AI
Hypothermic Storage and Cryopreservation of Corneas
$402,445J M Baust · Cell Preservation Services, Inc. · R44 · FY2009 · EY
Nitric Oxide as a Modifier of Oxidative Stress
$402,444David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
COMBINING NANOTECHNOLOGY AND RADIATION TO ENHANCE CHECKPOINT BLOCKADE IMMUNOTHERAPY OF ADVANCED PROSTATE CANCER
$402,428University Of Chicago · · FY2018 · Defense Health Agency
Clinical and Analytical Validation of Cancer Biomarkers
$402,374Daniel W Chan · Johns Hopkins University · U24 · FY2011 · CA
The structural and functional basis of MET exon 14 activation and acquired drug resistance
$402,355Natalia Jura · University Of California, San Francisco · R01 · FY2022 · CA
SOUTHWEST ONCOLOGY GROUP--SUMMARY
$402,352Loyola University Chicago · U10 · FY2003 · CA
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters
$402,346Avner Schlessinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium
$402,325Cory Abate-Shen · Columbia University Health Sciences · U01 · FY2011 · CA
Tumor Cell Biology Training Program
$402,313Gay Miriam Crooks · University Of California Los Angeles · T32 · FY2015 · CA
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies
$402,262Kris C. Wood · Duke University · R01 · FY2023 · CA
Novel Androgen Receptor Degraders to Treat Castration-Resistant Prostate Cancer
$402,226Ian Taylor · Arvinas, Inc. · R44 · FY2017 · CA
Evaluation of Immune-based Combinations in Metastatic Prostate Cancer
$402,223Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Controlled Release of Macromolecules
$402,150Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2010 · EB